Regulators approved an RSV antibody treatment for infants that provides vaccine-like protection over the course of a single winter respiratory virus season.
First RSV antibody treatment to protect all infants approved in the U.S.
Regulators approved an RSV antibody treatment for infants that provides vaccine-like protection over the course of a single winter respiratory virus season.